India, May 29 -- Indian Institute of Technology Madras (IIT-M) has developed an injectable hydrogel that could transform the treatment of fibrosis and other chronic degenerative conditions by replacing weeks of repeated medication with a single localised dose.

The researchers estimate that treatment could possibly reduce therapy costs from approximately $2,000-3,000 per course to around $300, potentially making advanced fibrosis care more affordable and accessible.

Developed at the Tissue Engineering and Biomaterials Laboratory, Department of Biotechnology, IIT Madras, the innovation is designed to deliver antifibrotic and anti-inflammatory drugs directly at the affected site in a sustained and controlled manner.

A key differentiator o...